Nu-Med Plus (NUMD) 10-Q 19 Aug 20 2020 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	Aug. 19, 2020	Jun. 30, 2020
Details
Registrant CIK		0001543637
Fiscal Year End		--12-31
Registrant Name		Nu-Med Plus, Inc.
SEC Form		10-Q
Period End date		Jun. 30, 2020
Tax Identification Number (TIN)		45-3672530
Number of common stock shares outstanding	50,228,469
Filer Category		Non-accelerated Filer
Current with reporting		Yes
Interactive Data Current		Yes
Shell Company		false
Small Business		true
Emerging Growth Company		true
Ex Transition Period		false
Entity File Number		000-54808
Entity Incorporation, State or Country Code		UT
Entity Address, Address Line One		455 East 500 South, Suite 203
Entity Address, City or Town		Salt Lake City
Entity Address, State or Province		UT
Entity Address, Postal Zip Code		84111
City Area Code		801
Local Phone Number		746-3570
Entity Listing, Par Value Per Share	$ 0.001
Amendment Flag		false
Document Fiscal Year Focus		2020
Document Fiscal Period Focus		Q2
Document Quarterly Report		true
Document Transition Report		false

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current assets
Cash	$ 6,106	$ 7,079
Prepaid expense	826,655	6,879
Total current assets	832,761	13,958
Long-term assets
Property and equipment, net	17,329	23,425
Operating lease right-of-use of assets	2,148	8,396
Total long-term assets	19,477	31,821
Total assets	852,238	45,779
Current liabilities
Accounts payable	58,049	39,820
Accounts payable - related party	22,111	14,085
Accrued expenses	6,586	9,579
Accrued interest - related party	112,273	114,231
Operating lease liability	2,148	8,396
Convertible Promissory Notes - Related party	230,100	230,100
Total current liabilities	431,267	416,211
Long-term liabilities
Note payable	9,384	0
Long-term liabilities	9,384	0
Total liabilities	440,651	416,211
Commitments and contingencies	0	0
Stockholders' equity (deficit)
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, respectively.	0	0
Common stock; $0.001 par value; 90,000,000 authorized; 50,228,469 and 44,476,625 shares issued and outstanding, as of June 30, 2020 and December 31, 2019, respectively.	50,229	44,477
Additional paid-in capital	8,132,393	5,849,784
Stock subscription payable	21,000	465,541
Accumulated deficit	(7,792,035)	(6,730,234)
Total stockholders' deficit	411,587	(370,432)
Total liabilities and stockholders' deficit	$ 852,238	$ 45,779

Condensed Balance Sheets - Pare

Condensed Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2020	Dec. 31, 2019
Details
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	90,000,000	90,000,000
Common Stock, Shares, Issued	50,228,469	44,476,625
Common Stock, Shares, Outstanding	50,228,469	44,476,625

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Details
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses
General and administrative expense	29,582	11,335	37,985	49,852
Payroll expense	503,858	64,486	571,333	125,980
Rent expense	4,690	4,598	9,379	9,197
Professional and consulting fees	363,269	159,945	428,966	475,288
Depreciation expense	3,048	3,421	6,096	7,196
Total operating expenses	904,446	243,785	1,053,759	667,513
Operating Loss	(904,446)	(243,785)	(1,053,759)	(667,513)
Other expense
Interest expense	(4,021)	(4,399)	(8,042)	(8,866)
Total other expense	(4,021)	(4,399)	(8,042)	(8,866)
Income tax expense	0	0	0	0
Net loss	$ (908,467)	$ (248,184)	$ (1,061,801)	$ (676,379)
Basic and diluted earnings (loss) per share	$ (0.02)	$ 0	$ (0.02)	$ (0.01)
Weighted average common shares outstanding - basic and diluted	47,336,288	45,336,283	47,352,260	45,129,067

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Other Additional Capital	Retained Earnings	Total
Stock issued for cash		200,000
Stock issued for cash	$ 0	$ 200	$ 49,800	$ 0	$ 0	$ 50,000
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2018	0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018		41,274,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 0	$ 41,274	4,851,487	849,175	(5,693,409)	48,527
Common Stock issued under subscription		40,000
Proceeds from issuance of common stock	0	$ 40	9,960	(10,000)	0	0
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	$ 0	$ 0	0	0	(428,195)	(428,195)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019		$ 41,514	4,961,247	849,175	(6,121,604)	$ (224,668)
Stock issued for cash						200,000
Stock issued for cash						$ 50,000
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2018	0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2018		41,274,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 0	$ 41,274	4,851,487	849,175	(5,693,409)	48,527
Stock issued for accrued interest on convertible note						0
Stock issued for services performed						100,000
Net income (loss)						(676,379)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	0	$ 41,514	5,011,247	1,009,773	(6,369,788)	(307,254)
Stock subscription payable - cash	0	$ 0	0	55,000	0	55,000
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019		$ 41,514	4,961,247	849,175	(6,121,604)	(224,668)
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	0	$ 0	0	0	(248,184)	(248,184)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2019		41,514,375
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	0	$ 41,514	5,011,247	1,009,773	(6,369,788)	(307,254)
Stock subscription payable - cash	$ 0	$ 0	0	115,598	0	$ 115,598
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2019	0					0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 0	$ 44,477	5,849,784	465,541	(6,730,234)	$ (370,432)
Stock issued for services performed	0	0	50,000	0	0	50,000
Net income (loss)	$ 0	$ 0	0	0	(153,334)	(153,334)
Common Stock, Shares, Outstanding, Ending Balance at Mar. 31, 2020		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2020		$ 44,447	5,899,784	571,980	(6,883,568)	$ (367,327)
Preferred Stock, Shares Outstanding, Beginning Balance at Dec. 31, 2019	0					0
Common Stock, Shares, Outstanding, Beginning Balance at Dec. 31, 2019		44,476,625				44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019	$ 0	$ 44,477	5,849,784	465,541	(6,730,234)	$ (370,432)
Common Stock issued under subscription						2,706,844
Stock issued for accrued interest on convertible note						1,000,000
Stock issued for accrued interest on convertible note						$ 10,000
Stock issued for prepaid services						$ 940,500
Stock issued for services performed						500,000
Stock issued for services performed						$ 661,150
Net income (loss)						$ (1,061,801)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	0	$ 50,229	8,132,393	21,000	(7,792,035)	$ 411,587
Stock subscription payable - cash	0	$ 0	0	106,439	0	106,439
Common Stock, Shares, Outstanding, Beginning Balance at Mar. 31, 2020		44,476,625
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2020		$ 44,447	5,899,784	571,980	(6,883,568)	(367,327)
Common Stock issued under subscription		2,706,844
Proceeds from issuance of common stock	0	$ 2,707	674,004	(676,711)	0	0
Stock issued for accrued interest on convertible note		1,000,000
Stock issued for accrued interest on convertible note	0	$ 1,000	9,000	0	0	10,000
Stock issued for prepaid services		1,400,000
Stock issued for prepaid services	0	$ 1,400	939,100	0	0	940,500
Stock issued for services performed		645,000
Stock issued for services performed	0	$ 645	610,505	0	0	611,150
Net income (loss)	0	$ 0	0	0	(908,467)	$ (908,467)
Common Stock, Shares, Outstanding, Ending Balance at Jun. 30, 2020		50,228,469				50,228,469
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2020	0	$ 50,229	8,132,393	21,000	(7,792,035)	$ 411,587
Stock subscription payable - cash	$ 0	$ 0	$ 0	$ 125,731	$ 0	$ 125,731

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows	3 Months Ended	6 Months Ended
	Jun. 30, 2020USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2019USD ($)
Cash flows from operating activities:
Net income (loss)	$ (908,467)	$ (1,061,801)	$ (676,379)
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization		6,096	7,196
Amortization of prepaid consulting	119,749	119,749	0
Amortization of right of use asset		6,248	6,047
Stock issued for services performed	611,150	661,150	100,000
(Increase) decrease in prepaid expenses		975	213,224
(Increase) decrease in operating lease liability		(6,248)	(6,047)
Increase (decrease) in accounts payable		18,229	(2,204)
Increase (decrease) in related party payables		8,026	0
Increase (decrease) in accrued expense		5,049	(9,051)
Net cash used in operating activities		(242,527)	(367,214)
Cash flows from investing activities:
Net cash used in investing activities		0	0
Cash flows from financing activities
Proceeds from stock subscriptions payable		232,170	170,598
Proceeds from notes payable		9,384	0
Proceeds from issuance of common stock		0	50,000
Payments on financing lease		0	(5,211)
Net cash provided by financing activities		241,554	215,387
Net increase (decrease) in cash		(973)	(151,827)
Cash at beginning of period		7,079	167,513
Cash at end of period	6,106	6,106	15,686
Supplemental schedule of cash flow information
Cash paid for interest		0	878
Cash paid for income tax		0	0
Common stock issued for subscription payable	676,711	676,711	10,000
Right-of-use operating lease assets obtained in exchange for operating lease liabilities		0	8,063
Conversion of accrued interest for common stock	$ 10,000	10,000	0
Common stock issued for prepaid services		$ 940,500	$ 0

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2020
Notes
Organization and Description of Business	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The recent COVID 19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our contract developers. The wide ranging effects on the World Wide business market has led to a closure or partial closure of firms we are relying on in our product development. As a result their work on our project has been slowed. While we cannot predict when the influence of the Pandemic will end, we trust businesses will be able to open and expand activities to their former levels and increase following a return to normal operations. a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020. b. Revenue Recognition The Financial Accounting Standards Board (“FSB”) issued new guidance for the recognizing and reporting of revenue in contracts with customers. The effective date for implementation for public companies is January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. Identify the contract with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when, or as, the reporting organization satisfied a performance obligation. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606. c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures. e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years. f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis. g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 84,000 and 4,035,340 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three and six months ended June 30, 2020 and 2019, respectively. Three months ended June 30, 2020 Three months ended June 30, 2019 Six months ended June 30, 2020 Six months ended June 30, 2019 Net loss (numerator) $(908,467) $(248,184) $(1,061,801) $(676,379) Shares (denominator) 47,336,288 45,336,283 47,352,260 45,129,067 Net loss per share amount – basic and diluted $(0.02) $(0.00) $(0.02) $(0.01) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of June 30, 2020 and 2019 there were 35,175,700 and 33,620,000, respectively, potential dilutive shares that needed to be considered as common share equivalents. As of June 30, 2020 and 2019 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive. h. Concentrations and Credit Risk - i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date The Company, in accordance with ASC 505, Compensation – Stock Compensation k. Leases The Company accounts for all leases in accordance with ASC 842, Leases l. Recent Accounting Pronouncements In June 2018, the FASB issued ASU No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity — Equity-Based Payments to Nonemployees”. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019. Early adoption is permitted, but no earlier than a company’s adoption date of ASU No. 2014-09, (Topic 606), “Revenue from Contracts with Customers”. The Company adopted ASU 2018-07 effective January 1, 2020. The adoption of ASU 2018-07 did not have a material effect on its condensed financial statements. In December 2019, the FASB issued ASU 2019-12, “Income Taxes Topic 740-Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes/. ASU 2019-12 removes certain exceptions to the general principles of Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. The effective date will be the first quarter of fiscal year 2021 and early adoption is permitted. Adoption of Topic 740 is not expected to have a material effect on its condensed financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2020
Notes
GOING CONCERN	NOTE 2 - GOING CONCERN The Company acknowledges that the funds on hand as of June 30, 2020, will not be sufficient to enable it to execute its business plan and funding through the sale of equity capital and short term related party and other shareholder loans in order to meet the planned expenditures for development, operations, and administrative cost over the next 12 months will be required. Planned expenditures are approximately $1,200,000 for the next twelve months. The Company is currently funded through August 31, 2020. If plans to obtain further financing prove to be insufficient to fund operations, continued viability could be at risk. These factors raise substantial doubt about the Company's ability to continue as a going concern.

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2020
Notes
Property and Equipment	NOTE 3 – PROPERTY AND EQUIPMENT Property and equipment and related accumulated depreciation consisted of the following at June 30, 2020, and December 31, 2019: June 30, 2020 December 31, 2019 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (73,039) (66,943) Total Fixed Assets $ 17,329 $ 23,425 Depreciation expense for the six months ended June 30, 2020 and 2019 was $6,096 and $7,196, respectively.

Preferred and Common Stock

Preferred and Common Stock	6 Months Ended
	Jun. 30, 2020
Notes
Preferred and Common Stock	NOTE 4 - PREFERRED STOCK On October 19, 2011, the Company filed Articles of Incorporation with the State of Utah so as to authorize 10,000,000 shares of preferred stock having a par value of $0.001 per share. No preferred shares are issued or outstanding at June 30, 2020. NOTE 5 - COMMON STOCK Stock Subscription Payable At June 30, 2020 and December 31, 2019, the Company had $21,000 and $465,541, respectively, in stock subscriptions payable for which it is obligated to issue 84,000 and 1,862,164 shares of restricted common stock, respectively, pursuant to separate subscription agreements. April 2020 Subscription Agreement In April 2020, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. The agreement expires on December 31, 2021. The Company received $103,106 under this agreement in the six months ended June 30, 2020. At the date of this report 328,424 shares of common stock have been issued, leaving a balance of 84,000 shares to be issued. As of June 30, 2020 a total of 1,187,576 shares of common stock for $296,894 are available for purchase under this agreement. July 2019 Subscription Agreement In July 2019, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $250,000 in shares of common stock at $0.25 per share. The agreement expires on December 31, 2020. The Company received $250,000under this agreement and in June 2020 1,000,000 shares of common stock in settlement of its obligations under this agreement. September 2017 Subscription Agreement In September 2017, the Company entered into a stock purchase agreement with a related party, significant shareholder and debt holder, under which the buyer may purchase up to $400,000 in shares of common stock at $0.25 per share. This agreement expired on August 30, 2018. The Company received $153,070 under this agreement during 2018 and $246,930 during 2019. As of December 31, 2019, the Company had stock subscription payables related to this agreement of $344,605 or 1,378,420 shares of common stock. In the six months ended June 30, 2020, the Company issued the 1,378,420 shares of common stock in settlement of its obligation under this agreement. In the six months ended June 30, 2020 the Company issued 5,751,844 shares of common stock. Of the total 2,706,844 was issued in settlement of stock subscriptions payable, 1,000,000 shares were issued from the conversion of accrued interest on notes payable, and 2,045,000 was issued for services performed and services to be performed. Common Stock Issued for Cash During the six months ending June 30, 2019, the Company issued 200,000 shares of restricted common stock for $50,000 to an unrelated investor. Common Stock Issued for conversion of liabilities During the six months ended June 30, 2020, the Company issued 1,000,000 shares of restricted common stock in exchange for the conversion of $10,000 of accrued interest on notes payable. Common Stock Issued to Officer On February 14, 2018 the Company announced that the consulting agreement with the Chief Financial Officer (Mr. Merrell) was terminated effective December 31, 2017, and that a new agreement was entered into effective January 1, 2018 under which Mr. Merrell would receive 2,000,000 shares of restricted common stock, vesting at 500,000 shares per year, for his service. The term of the agreement is for one year, which term automatically renews for one year extensions up to four years unless terminated by either party with 30 days written notice. The Company issued all 2,000,000 shares to Mr. Merrell on August 20, 2018. Any common shares not earned during the four year period are to be returned or cancelled. A charge will be made each quarter as the shares are earned under the provisions of the agreement until such time as all shares have been earned. A charge of $100,000 and $100,000 were recorded for the six months ended June 30, 2020 and 2019, respectively. In June 2020 Mr. Merrell was issued an additional 500,000 shares which vested at issuance, resulting in a $435,000 stock-based compensation charge recorded in the six-month period ended June 30, 2020. Common Stock Issued for Services During the six months ended June 30, 2020 the Company issued 1,545,000 shares of restricted common stock to consultants for services performed and/or to be performed. The issuances were valued at $1,601,650 and of that amount, $940,500 was recorded as prepaid assets. The Company incurred stock-based compensation of $245,899 during the six-months ended June 30, 2020. As of June 30, 2020, the remaining prepaid balance of $820,751 remains to be amortized as the services are performed. In September 2018, the Company issued 650,000 shares of stock to two consultants. Of these shares, 150,000 were issued under a consulting contract for services rendered and vested upon issue and 500,000 shares of restricted stock were issued to a consultant for services rendered and to be rendered through June 1, 2019. The common stock was valued at $639,000, of which $432,750 was expensed during the year ended December 31, 2018. The remaining balance of $206,250 was expensed during the year ended December 31, 2019.

Convertible Notes and Derivativ

Convertible Notes and Derivative Liability	6 Months Ended
	Jun. 30, 2020
Notes
Convertible Notes and Derivative Liability	NOTE 6 – PROMISSORY NOTES $100,000 Convertible Promissory Note On November 12, 2012, the Company issued a $100,000 convertible promissory note to SCS, a related party and significant shareholder, as compensation for services provided during the period April 1, 2012 through March 31, 2013. The note is due on demand, had an annual interest of 5.5%, and is convertible into shares of common stock at a conversion price to be agreed upon immediately prior to conversion. On September 27, 2013, the Company amended the note to include a conversion price which of $0.01 per share for all unpaid principal and interest. As of June 30, 2020 and December 31, 2019 interest accrued, but unpaid, was $63,733 and $60,953, respectively. $130,100 Convertible Promissory Note Prior to 2015, the Company entered into a convertible promissory note with SCS, a related party and significant shareholder, due on demand, bearing interest at 8% per annum, unsecured and convertible at $0.01 per share, with a price protection provision to a lower conversion price. The balance of this note was $130,100 at June 30, 2020 and December 31, 2019 with the accrued interest balances of $47,747 and $52,557, respectively. During the six-month period ended June 30, 2020, the Company received a request to convert $10,000 of interest accrued and unpaid to shares of restricted common stock. Under the conversion terms of the agreement 1,000,000 shares of restricted stock were issued. $9,384 Promissory Note The Company applied for and received a $9,384 loan under the Paycheck Protection Program administered by the Small Business Administration. The note bears an annual interest rate of 1% and has a maturity date of May 8, 2022. The terms of the loan provide that an application for forgiveness of the loan amount may be requested if the funds were used for payroll, medical insurance, rent and utilities. As all of the funds were used in the allowable categories, the Company will file an application for forgiveness as soon as the bank makes available the form for such request.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2020
Notes
Commitments and Contingencies	NOTE 7 - COMMITMENTS AND CONTINGENCIES The Company has obligations under both a financing lease and operating lease, as detailed below. Operating Lease Obligations The Company entered into a lease for office space in February 2017 for $950 per month. In November 2017 the Company signed a six-month extension of the lease with a lease payment of $978 per month. In March 2018 the Company extended the lease agreement through August 31, 2019 at a rate of $1,008 Amortization of $6,248 was recorded as rent expense in the six month period ended June 30, 2020, leaving an operating right-of-use asset at June 30, 2020 of $2,148 and an operating lease liability of $2,148. Amortization of $6,047 was recorded as rent expense for the six month period ended June 30, 2019. Obligations under this lease are as follows: 2020 2021 2022 Office lease $ 2,076 $ - $ - Upon the adoption of ASC 842, the calculation of our lease obligation using a discount rate of 8% resulted in an immaterial difference and therefore, no interest will be imputed on the lease obligation. Consulting Agreement In June 2020, the Company entered into consulting agreements with Roger Gill and Peter Kristensen. Both of the agreements begin June 22, 2020 and run for a period of twelve months, terminating June 30, 2021. Under the terms of the agreements Mr. Gill will receive 500,000 shares of restricted common stock and Mr. Kristensen will receive 100,000 shares of restricted stock for their services. The fair-value of the stock was $565,500 and was recorded as a prepaid. During the six months, the company amortized $10,845 of the prepaid expense. As of June 30, 2020, the remaining $554,655 was remaining in prepaid expenses, to be amortized over the term of the agreements. On March 15, 2020 the Company entered into a service agreement with Hanover International, Inc. to provide advisory services to the Company. The contract is a one year contract, but may be cancelled with thirty days notice any time after the 91 st day of the agreement. Hanover will receive a fee of $ 3,500 per month, from which fee it pays all of its expenses. In addition, Hanover will receive 750,000 shares of restricted common stock, earned in quarterly tranches of 187,500 shares, deemed earned and issuable after services are provided for each quarter. As of June 30, 2020 all of the shares to which the Company is obligated under this agreement have been issued, with the unearned portion included in prepaid expenses. The shares were issued at $ 0.50 per share for a total value of $ 375,000 . The amount is found in prepaid expenses, with $ 108,904 of the total being expensed in the six-month period ended June 30, 2020. The remaining prepaid amount will be amortized over the remaining life of the agreement.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2020
Notes
Subsequent Events	NOTE 8 - SUBSEQUENT EVENTS The Company has evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that require disclosure as of the date of issuance.

Organization and Description _2

Organization and Description of Business (Policies)	6 Months Ended
	Jun. 30, 2020
Policies
Accounting Method	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The recent COVID 19 Pandemic (“the Pandemic”) has had a dramatic effect on our business as well as the business of our contract developers. The wide ranging effects on the World Wide business market has led to a closure or partial closure of firms we are relying on in our product development. As a result their work on our project has been slowed. While we cannot predict when the influence of the Pandemic will end, we trust businesses will be able to open and expand activities to their former levels and increase following a return to normal operations. a. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of Nu-Med Plus, Inc. (the “Company”). These financial statements are condensed and, therefore, do not include all disclosures normally required by accounting principles generally accepted in the United States of America. Therefore, these statements should be read in conjunction with the most recent annual consolidated financial statements of Nu-Med Plus, Inc. for the year ended December 31, 2019 included in the Company’s Form 10-K filed with the Securities and Exchange Commission on March 30, 2020. In particular, the Company’s significant accounting principles were presented as Note 1 to the Consolidated Financial Statements in that report. In the opinion of management, all adjustments necessary for a fair presentation have been included in the accompanying condensed consolidated financial statements and consist of only normal recurring adjustments. The results of operations presented in the accompanying condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the full year ending December 31, 2020.
Revenue Recognition	b. Revenue Recognition The Financial Accounting Standards Board (“FSB”) issued new guidance for the recognizing and reporting of revenue in contracts with customers. The effective date for implementation for public companies is January 1, 2018. The new guidance established a five-step analysis to be followed when determining the recognition of revenue. 1. Identify the contract with a customer. 2. Identify the performance obligations in the contract. 3. Determine the transaction price. 4. Allocate the transaction price to the performance obligations in the contract. 5. Recognize revenue when, or as, the reporting organization satisfied a performance obligation. While the Company is an early-stage company with no revenue, at the time we begin to generate revenue the Company will recognize such revenue in conformity with the guidelines set forth by ASC 606.
Estimates	c. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	d. Cash and Cash Equivalents The Company considers all deposit accounts and investment accounts with an original maturity of 90 days or less to be cash equivalents. The cash balance we currently have on deposit is within the limits for which the FDIC insures.
Property and equipment	e. Property and Equipment Property and equipment is stated at cost. Expenditure for minor repairs, maintenance, and replacement parts which do not increase the useful lives of the assets are charged to expense as incurred. Expenditures, exceeding $500, for new assets or that increase the useful life of existing assets are capitalized. Depreciation is computed using the straight-line method. The lives over which the fixed assets are depreciated are five to seven years.
Fair Value	f. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB Accounting Standards Codification (“ASC”) Topic 820 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements), as follows: Level 1 - Quoted market prices in active markets for identical assets or liabilities; Level 2 - Inputs other than level one inputs that are either directly or indirectly observable; and Level 3 - Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. All cash, accounts payable and accrued liabilities are carried at cost, which approximates fair value due to the short-term nature of these financial instruments. Additionally, we measure certain financial instruments at fair value on a recurring basis.
Earnings Per Share	g. Earnings per Share The computation of earnings per share of common stock is based on the weighted average number of shares outstanding during the period of the financial statement. The company included 84,000 and 4,035,340 shares subscribed but unissued in its calculation of basic and diluted earnings per share for the three and six months ended June 30, 2020 and 2019, respectively. Three months ended June 30, 2020 Three months ended June 30, 2019 Six months ended June 30, 2020 Six months ended June 30, 2019 Net loss (numerator) $(908,467) $(248,184) $(1,061,801) $(676,379) Shares (denominator) 47,336,288 45,336,283 47,352,260 45,129,067 Net loss per share amount – basic and diluted $(0.02) $(0.00) $(0.02) $(0.01) Diluted earnings per share is computed using the weighted average number of common shares plus dilutive common share equivalents outstanding during the period. As of June 30, 2020 and 2019 there were 35,175,700 and 33,620,000, respectively, potential dilutive shares that needed to be considered as common share equivalents. As of June 30, 2020 and 2019 the dilutive shares were excluded from the calculation for diluted earnings per share as there was a net loss and their inclusion in the calculation would be anti-dilutive.
Concentration and Credit Risk	h. Concentrations and Credit Risk -
Income Taxes	i. Income Taxes Deferred taxes are provided on an asset and liability approach whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Equity Instruments Issued For Non-cash Items	j. Stock-based Compensation The Company, in accordance with ASC 718, Compensation – Stock Compensation Measurement Objective – Fair Value at Grant Date The Company, in accordance with ASC 505, Compensation – Stock Compensation
Leases	k. Leases The Company accounts for all leases in accordance with ASC 842, Leases
New Accounting Pronouncements	l. Recent Accounting Pronouncements In June 2018, the FASB issued ASU No. 2018-07, “Compensation — Stock Compensation (Topic 718),” (“ASU 2018-07”). ASU 2018-07 is intended to reduce cost and complexity of financial reporting for non-employee share-based payments. Currently, the accounting requirements for non-employee and employee share-based payments are significantly different. ASU 2018-07 expands the scope of Topic 718, which currently only includes share-based payments to employees, to include share-based payments to non-employees for goods or services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, “Equity — Equity-Based Payments to Nonemployees”. The amendments to ASU 2018 - 07 are effective for fiscal years beginning after December 15, 2018, and interim periods within fiscal years beginning after December 15, 2019. Early adoption is permitted, but no earlier than a company’s adoption date of ASU No. 2014-09, (Topic 606), “Revenue from Contracts with Customers”. The Company adopted ASU 2018-07 effective January 1, 2020. The adoption of ASU 2018-07 did not have a material effect on its condensed financial statements. In December 2019, the FASB issued ASU 2019-12, “Income Taxes Topic 740-Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which intended to simplify various aspects related to accounting for income taxes/. ASU 2019-12 removes certain exceptions to the general principles of Topic 740 and also clarifies and amends existing guidance to improve consistent application of Topic 740. The effective date will be the first quarter of fiscal year 2021 and early adoption is permitted. Adoption of Topic 740 is not expected to have a material effect on its condensed financial statements. The Company has reviewed all other recently issued, but not yet adopted, accounting standards in order to determine their effects, if any, on its consolidated results of operation, financial position and cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its current or future earnings or operations.

Organization and Description _3

Organization and Description of Business (Tables)	6 Months Ended
	Jun. 30, 2020
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	Three months ended June 30, 2020 Three months ended June 30, 2019 Six months ended June 30, 2020 Six months ended June 30, 2019 Net loss (numerator) $(908,467) $(248,184) $(1,061,801) $(676,379) Shares (denominator) 47,336,288 45,336,283 47,352,260 45,129,067 Net loss per share amount – basic and diluted $(0.02) $(0.00) $(0.02) $(0.01)

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2020
Tables/Schedules
Property, Plant and Equipment	June 30, 2020 December 31, 2019 Computer and office equipment $ 90,368 $ 90,368 Accumulated depreciation (73,039) (66,943) Total Fixed Assets $ 17,329 $ 23,425

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2020
Tables/Schedules
Schedule of Future Minimum Lease Payments for Capital Leases	2020 2021 2022 Office lease $ 2,076 $ - $ -

Organization and Description _4

Organization and Description of Business (Details) - USD ($)	Dec. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Details
Stock Issued During Period, Shares, Period Increase (Decrease)	1,862,164			84,000	4,035,340
Net Income (Loss) Available to Common Stockholders, Basic		$ (908,467)	$ (248,184)	$ (1,061,801)	$ (676,379)
Weighted Average Number of Shares Outstanding, Basic		47,336,288	45,336,283	47,352,260	45,129,067
Basic and diluted earnings (loss) per share		$ (0.02)	$ 0	$ (0.02)	$ (0.01)
Dilutive Shares		35,175,700	33,620,000

GOING CONCERN (Details)

GOING CONCERN (Details)	6 Months Ended
	Jun. 30, 2020USD ($)
Details
Planned expenditures	$ 1,200,000

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Details
Property, Plant and Equipment, Gross	$ 90,368		$ 90,368		$ 90,368
Accumulated Depreciation	(73,039)		(73,039)		(66,943)
Property and equipment, net	17,329		17,329		$ 23,425
Depreciation expense	$ 3,048	$ 3,421	$ 6,096	$ 7,196

Preferred and Common Stock (Det

Preferred and Common Stock (Details) - USD ($)	Apr. 02, 2020	Dec. 31, 2019	Jul. 02, 2019	Dec. 31, 2018	Jun. 30, 2020	Sep. 30, 2018	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019	Dec. 31, 2018	Sep. 02, 2017
Details
Preferred Stock, Shares Authorized		10,000,000			10,000,000		10,000,000				10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share		$ 0.001			$ 0.001		$ 0.001				$ 0.001		$ 0.001
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable		$ 465,541			$ 21,000		$ 21,000				$ 21,000		$ 465,541
Stock Issued During Period, Shares, Period Increase (Decrease)		1,862,164									84,000	4,035,340
400,000 Stock Subscription Amount											$ 400,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price	$ 0.25		$ 0.25												$ 0.25
400,000 Amount Used From Subscription											103,106		246,930
Shares Issued Under $400,000 Stock Purchase Agreement	328,424
Shares Under $400,000 Stock Purchase Agreement	1,187,576
400,000 Amount Available From Subscription											296,894
250,000 Stock Subscription Amount											250,000
250,000 Amount Used From Subscription											$ 250,000
Shares Under $250,000 Stock Purchase Agreement			1,000,000
400,000 Amount Used From Subscription In Prior Periods														$ 153,070
Stock Subscription Payable Related to $400000		$ 344,605											$ 344,605
Remaining Shares Under $400,000 Stock Purchase Agreement		1,378,420
Total Shares Issued											5,751,844
Common Stock issued under subscription											2,706,844
Stock issued for accrued interest on convertible note											1,000,000
Total Shares Issued for services performed and to be performed											2,045,000
Stock issued for cash												200,000
Stock issued for cash										$ 50,000		$ 50,000
Conversion of accrued interest for common stock							10,000				$ 10,000	0
Merrell stock compensation											2,000,000
Stock issued for services performed					1,545,000	650,000					500,000
Stock issued for services performed						$ 639,000	611,150	$ 50,000	$ 50,000	$ 50,000	$ 661,150	$ 100,000
Merrell additional stock compensation											500,000
Merrell additional stock compensation Amount											$ 435,000
1545000 shares issued for services											1,601,650
Stock issued for prepaid services							$ 940,500				940,500
1545000 shares issued for services amount paid											245,899
1545000 shares issued for services amount balance											$ 820,751
Consulting stock compensation 1											150,000
Consulting stock compensation 2											500,000
Consulting expense		$ 206,250		$ 432,750

Convertible Notes and Derivat_2

Convertible Notes and Derivative Liability (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019	Nov. 12, 2012
Details
SCS convertible promissory note principal	$ 63,733	$ 63,733		$ 60,953	$ 100,000
SCS convertible promissory note interest rate	5.50%	5.50%
SCS convertible promissory note conversion price	$ 0.01	$ 0.01
130,100 convertible promissory note interest rate		8.00%
130,100 convertible promissory note conversion price		$ 0.01
130,100 convertible promissory note principal balace	$ 130,100	$ 130,100
130,100 convertible promissory note accrued interest	47,747	47,747		52,557
Conversion of accrued interest for common stock	10,000	$ 10,000	$ 0
Stock issued for accrued interest on convertible note		1,000,000
Note payable	$ 9,384	$ 9,384		$ 0

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($)	1 Months Ended	6 Months Ended		7 Months Ended	12 Months Ended	14 Months Ended
	Jun. 30, 2020	Jun. 30, 2020	Jun. 30, 2019	May 31, 2018	Jun. 30, 2019	Aug. 31, 2020	Dec. 31, 2019
Details
monthly office lease payment		$ 950		$ 978	$ 1,008	$ 1,038
Amortization of right of use asset		6,248	$ 6,047
Operating lease right-of-use of assets	$ 2,148	2,148					$ 8,396
Operating lease liability	2,148	2,148					$ 8,396
Capital Leases, Future Minimum Payments Due, Next Twelve Months	$ 2,076	2,076
Gill shares received in consulting agreement	500,000
Kristensen shares received in consulting agreement	100,000
Gill and Kristensen Consulting shares value total	$ 565,500
Gill and Kristensen Consulting shares amount amortized	10,845
Gill and Kristensen Consulting shares amount remaining	$ 554,655
Hanover compensation monthly payment		$ 3,500
Hanover total compensation shares		750,000
Hanover tranche compensation shares		187,500
Hanover price per share		$ 0.50
Hanover total value		$ 375,000
Hanover Amount Expensed		$ 108,904